Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Digital Health, Cybersecurity Would See Significant Chunk Of FDA Device-Funding Boost

Executive Summary

If Congress approves a 26% higher 2019 funding request for US FDA's device center, a substantial chunk of those dollars would go to building a novel framework for regulating digital-health technologies, and to help FDA and device manufacturers respond better to cybersecurity vulnerabilities, among other program priorities, according to agency officials.

Advertisement

Related Content

New Safety Framework Mixes Current Efforts, New Investments At US FDA
Medtech Provisions Approved In US Budget Agreement
Coming Together On Pre-Cert: Digital Health World Engages With FDA To Hash Out Regulatory Future
9 Device-Makers Wanted For US FDA Pilot Program To Measure Quality System Maturity
US Homeland Security-Funded Project Aims To Solve Medtech Cybersecurity Problem
J&J, Hacker Work Together To Fix Insulin Pump Vulnerability
Shuren: FDA Willing to Kick-Start Device Evaluation Program, But Funding Guarantee Needed

Topics

Advertisement
UsernamePublicRestriction

Register

MT122203

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel